دورية أكاديمية

Meeting the transfusion needs of a patient with anti-En a requires an international effort.

التفاصيل البيبلوغرافية
العنوان: Meeting the transfusion needs of a patient with anti-En a requires an international effort.
المؤلفون: Chou ST; 1Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, US.; 2Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, US., Nance ST; 3Immunohematology Reference Laboratory, American Red Cross, Philadelphia, PA, US.; 4American Rare Donor Program, American Red Cross, Philadelphia, PA, US., Mansfield P; 3Immunohematology Reference Laboratory, American Red Cross, Philadelphia, PA, US., Friedman DF; 1Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, US.; 2Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, US., Keller MA; 4American Rare Donor Program, American Red Cross, Philadelphia, PA, US.; 5National Molecular Laboratory, American Red Cross, Philadelphia, PA, US.
المصدر: Immunohematology [Immunohematology] 2024 May 13; Vol. 40 (1), pp. 10-14. Date of Electronic Publication: 2024 May 13 (Print Publication: 2024).
نوع المنشور: Journal Article; Case Reports
اللغة: English
بيانات الدورية: Publisher: American Red Cross Country of Publication: United States NLM ID: 8806387 Publication Model: eCollection Cited Medium: Print ISSN: 0894-203X (Print) Linking ISSN: 0894203X NLM ISO Abbreviation: Immunohematology Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Washington, D.C.] : American Red Cross, [1984-
مواضيع طبية MeSH: Blood Group Antigens*/immunology , Blood Donors*, Humans ; Blood Transfusion ; Blood Grouping and Crossmatching/methods ; Qatar ; Male ; Female ; Blood Group Incompatibility/immunology
مستخلص: This extraordinary case showcases the identification of a rare anti-En a specificity that was assisted by DNA-based red blood cell antigen typing and collaboration between the hospital blood bank in the United States, the home blood center in Qatar, the blood center Immunohematology Reference Laboratory, as well as the American Rare Donor Program (ARDP) and the International Society for Blood Transfusion (ISBT) International Rare Donor Panel. En a is a high-prevalence antigen, and blood samples from over 200 individuals of the extended family in Qatar were crossmatched against the patient's plasma with one compatible En(a-) individual identified. The ISBT International Rare Donor Panel identified an additional donor in Canada, resulting in a total of two En(a-) individuals available to donate blood for the patient.
(© 2024 Stella T. Chou et al., published by Sciendo.)
References: 1. Ratliff J, Veneman S, Ward S, et al. An alloantibody to a high-prevalence MNS antigen in a person with a GP.JL/Mk phenotype. Immunohematology 2007;23:146–9.
2. Howard PJ, Guerra L, Kuttner DK, George MR. Clinical approach after identification of a rare anti-En a in a prenatal sample. Immunohematology 2019;35:159–61.
3. Walker PS, Bergren MO, Busch MP, Carmody AM, Perkins HA. Finnish En(a–) propositus with anti-EnaFS and anti-EnaFR: in vitro and in vivo characteristics. Vox Sang 1987;52:103–6.
4. Nance SJ, Lomas-Francis C; ISBT Working Party on Rare Donors. Where in the world are rare donors? A Working Party On Rare Donors Survey. Vox Sang 2020;115(Suppl 1):91.
5. Nance S, VanThof L, Kaherl K, et al. Survey of the American Rare Donor Program: new insights into enumerating rare donors and rare blood requests in the USA (abstract). Transfusion 2021;61(Suppl 3):17A.
فهرسة مساهمة: Keywords: Ena; alloimmunization; glycophorin; high-prevalence antigen; rare blood
المشرفين على المادة: 0 (Blood Group Antigens)
تواريخ الأحداث: Date Created: 20240513 Date Completed: 20240513 Latest Revision: 20240627
رمز التحديث: 20240627
DOI: 10.2478/immunohematology-2024-003
PMID: 38739026
قاعدة البيانات: MEDLINE
الوصف
تدمد:0894-203X
DOI:10.2478/immunohematology-2024-003